Medial augmentation plating of aseptic distal femoral nonunions.


Journal

BMC musculoskeletal disorders
ISSN: 1471-2474
Titre abrégé: BMC Musculoskelet Disord
Pays: England
ID NLM: 100968565

Informations de publication

Date de publication:
05 Jul 2023
Historique:
received: 28 10 2022
accepted: 27 06 2023
medline: 7 7 2023
pubmed: 6 7 2023
entrez: 5 7 2023
Statut: epublish

Résumé

Distal femur nonunions are well-recognized contributors to persistent functional disability, with limited data regarding their treatment options. In the current study, we asked whether additional medial augmentation plating is a feasible treatment option for patients with aseptic distal femoral nonunion and intact lateral implants. We conducted a single-center, retrospective study including 20 patients treated for aseptic distal femoral nonunion between 2002 and 2017. The treatment procedure included a medial approach to the distal femur, debridement of the nonunion site, bone grafting and medial augmentation plating utilizing a large-fragment titanium plate. Outcome measures were bone-related and functional results, measured by the Hospital for Special Surgery Knee Rating Scale (HSS) and the German Short Musculoskeletal Function Assessment questionnaire (SMFA-D). Eighteen of 20 nonunions showed osseous healing at 8.16 ± 5.23 (range: 3-21) months after augmentation plating. Regarding functional results, the mean HSS score was 74.17 ± 11.12 (range: 57-87). The mean SMFA-D functional index was 47.38 ± 16.78 (range 25.74-71.32) at the last follow-up. Index procedure-associated complications included two cases of persistent nonunion and one case of infection. According to the assessed outcome measures, augmentation plating is a feasible treatment option, with a high proportion of patients achieving bony union and good functional outcomes and a few patients experiencing complications.

Sections du résumé

BACKGROUND BACKGROUND
Distal femur nonunions are well-recognized contributors to persistent functional disability, with limited data regarding their treatment options. In the current study, we asked whether additional medial augmentation plating is a feasible treatment option for patients with aseptic distal femoral nonunion and intact lateral implants.
METHODS METHODS
We conducted a single-center, retrospective study including 20 patients treated for aseptic distal femoral nonunion between 2002 and 2017. The treatment procedure included a medial approach to the distal femur, debridement of the nonunion site, bone grafting and medial augmentation plating utilizing a large-fragment titanium plate. Outcome measures were bone-related and functional results, measured by the Hospital for Special Surgery Knee Rating Scale (HSS) and the German Short Musculoskeletal Function Assessment questionnaire (SMFA-D).
RESULTS RESULTS
Eighteen of 20 nonunions showed osseous healing at 8.16 ± 5.23 (range: 3-21) months after augmentation plating. Regarding functional results, the mean HSS score was 74.17 ± 11.12 (range: 57-87). The mean SMFA-D functional index was 47.38 ± 16.78 (range 25.74-71.32) at the last follow-up. Index procedure-associated complications included two cases of persistent nonunion and one case of infection.
CONCLUSIONS CONCLUSIONS
According to the assessed outcome measures, augmentation plating is a feasible treatment option, with a high proportion of patients achieving bony union and good functional outcomes and a few patients experiencing complications.

Identifiants

pubmed: 37407946
doi: 10.1186/s12891-023-06675-5
pii: 10.1186/s12891-023-06675-5
pmc: PMC10324211
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

554

Informations de copyright

© 2023. The Author(s).

Références

J Am Acad Orthop Surg. 2019 Jul 15;27(14):e659-e663
pubmed: 30407980
Unfallchirurgie (Heidelb). 2022 Aug;125(8):602-610
pubmed: 35750886
J Orthop Trauma. 1995 Feb;9(1):63-5
pubmed: 7714656
Orthop Surg. 2013 Feb;5(1):46-50
pubmed: 23420747
Clin Orthop Relat Res. 1996 Jun;(327):272-82
pubmed: 8641074
Eur J Orthop Surg Traumatol. 2019 Jan;29(1):189-196
pubmed: 29931530
J Bone Joint Surg Am. 2010 Dec;92 Suppl 2:12-22
pubmed: 21123589
Injury. 2005 Nov;36 Suppl 4:S30-7
pubmed: 16291321
Injury. 2014 Dec;45 Suppl 6:S93-7
pubmed: 25457326
J Bone Joint Surg Am. 2002 Feb;84(2):208-15
pubmed: 11861726
J Orthop Trauma. 2010 Mar;24(3):156-62
pubmed: 20182251
J Bone Joint Surg Am. 1992 Jun;74(5):659-70
pubmed: 1378056
Iowa Orthop J. 2010;30:61-8
pubmed: 21045973
J Arthroplasty. 1993 Feb;8(1):49-55
pubmed: 8436989
Int Orthop. 2005 Oct;29(5):287-90
pubmed: 16132986
JBJS Rev. 2016 Jun 14;4(6):
pubmed: 27486720
Musculoskelet Surg. 2020 Aug;104(2):215-226
pubmed: 31243698
Cochrane Database Syst Rev. 2015 Aug 13;(8):CD010606
pubmed: 26270891
Injury. 2006 May;37 Suppl 2:S59-66
pubmed: 16651073
JBJS Rev. 2015 Mar 17;3(3):
pubmed: 27490889
J Orthop Surg Res. 2013 Nov 27;8:43
pubmed: 24279475
Injury. 2007 Sep;38 Suppl 4:S3-6
pubmed: 18224731
J Orthop Trauma. 2011 Feb;25 Suppl 1:S8-14
pubmed: 21248560
J Trauma. 2008 Feb;64(2):434-8
pubmed: 18301211
Int Orthop. 2018 Nov;42(11):2675-2683
pubmed: 29516238
J Orthop Trauma. 1995;9(4):285-91
pubmed: 7562149
Clin Orthop Relat Res. 2016 Jun;474(6):1498-505
pubmed: 26797911
Qual Life Res. 2015 Aug;24(8):2015-23
pubmed: 25676859
J Orthop Trauma. 2002 May;16(5):287-96
pubmed: 11972070
J Orthop Trauma. 2020 Jan;34(1):8-17
pubmed: 31855973
J Trauma. 2011 Aug;71(2):E26-30
pubmed: 21248652
J Bone Joint Surg Am. 1982 Jul;64(6):871-9
pubmed: 7085714
Orthop Traumatol Surg Res. 2012 Feb;98(1):97-102
pubmed: 22244249
Occup Med (Lond). 2016 Dec;66(9):757
pubmed: 27994082
Arch Orthop Trauma Surg. 2022 Jun;142(6):1009-1030
pubmed: 33484313
J Orthop Trauma. 2018 Jan;32 Suppl 1:S1-S170
pubmed: 29256945
J Orthop Trauma. 2014 Feb;28(2):83-9
pubmed: 23760176
J Trauma. 1991 Dec;31(12):1659-62
pubmed: 1749039
J Orthop Res. 2000 Mar;18(2):289-302
pubmed: 10815831
J Orthop Trauma. 2001 Nov;15(8):574-8
pubmed: 11733676
Arch Orthop Trauma Surg. 2016 May;136(5):631-8
pubmed: 26852379
J Bone Joint Surg Am. 1999 Sep;81(9):1217-28
pubmed: 10505518
J Orthop Trauma. 2018 Feb;32 Suppl 1:S35-S39
pubmed: 29373450
J Orthop Surg Res. 2020 Apr 15;15(1):144
pubmed: 32293488
J Orthop Trauma. 2019 Nov;33(11):547-552
pubmed: 31403558
Arch Orthop Trauma Surg. 2021 Feb;141(2):225-233
pubmed: 32388648

Auteurs

Sebastian Lotzien (S)

Department of General and Trauma Surgery, Ruhr University Bochum, Bürkle-de-La-Camp-Platz 1, 44789, Bochum, Germany. SebastianLotzien@hotmail.com.

Darius Baron (D)

Department of General and Trauma Surgery, BG University Hospital Bergmannsheil, Bürkle- de- La- Camp Platz 1, 44789, Bochum, Germany.

Thomas Rosteius (T)

Department of General and Trauma Surgery, BG University Hospital Bergmannsheil, Bürkle- de- La- Camp Platz 1, 44789, Bochum, Germany.

Charlotte Cibura (C)

Department of General and Trauma Surgery, BG University Hospital Bergmannsheil, Bürkle- de- La- Camp Platz 1, 44789, Bochum, Germany.

Christopher Ull (C)

Department of General and Trauma Surgery, BG University Hospital Bergmannsheil, Bürkle- de- La- Camp Platz 1, 44789, Bochum, Germany.

Thomas Armin Schildhauer (TA)

Department of General and Trauma Surgery, BG University Hospital Bergmannsheil, Bürkle- de- La- Camp Platz 1, 44789, Bochum, Germany.

Jan Geßmann (J)

Department of General and Trauma Surgery, BG University Hospital Bergmannsheil, Bürkle- de- La- Camp Platz 1, 44789, Bochum, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH